ERAS Erasca, Inc.

track record → $9.90 -9.25 (-48.3%)
Get emailed when ERAS changes direction
Mkt Cap $7B 52wk $1.06 - $23.27 Earnings 2026-05-13
Factor Model (net +0.2)

Factor Model

net +0.2
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

1d ago Stifel main ERAS: Buy → Buy
15d ago Insider buy by CASDIN ALEXANDER W (ERAS): $181,920
Fundamentals & Data ▾
Erasca, Inc. Healthcare · Biotechnology
Mkt Cap
$7B
Beta
1.05
52w Range
$1.06 - $23.27
Short Interest
29.9M 10.79%
Days to Cover
5.3 +10%
Technicals downtrend
from 52w Hi
-14.8%
1w return
-11.8%
Insiders
selling 1B / 2S
Analysts
mixed
EPS Estimate
$-0.24 +0.6% 30d 2up / 2dn
Est. Dispersion
205% 7 analysts
Analyst Target
$20 $2 - $30
Options P/C
0.50
Insider Cluster
sell cluster 1B / 2S
Fund Convergence
strong Citadel, Renaissance, D.E. Shaw, Two Sigma
Top Holders
Citadel $4M
Renaissance $3M
D.E. Shaw $2M
Two Sigma
Recent Filings & Data
insider trade 7
net selling · $971,572 sold · $181,920 bought
4 insiders · 7 transactions (30d)
Recent transactions
MORRIS SHANNON R. M.D., PH.D. · sell · $300,760
MORRIS SHANNON R. M.D., PH.D. · exercise · $34,000
GARNER EBUN S · sell · $670,812
GARNER EBUN S · exercise · $204,000
GARNER EBUN S · award · $13,384
MULTANI PRATIK S · other
CASDIN ALEXANDER W · buy · $181,920
6 signals · latest 1d ago

Get alerted when ERAS changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.